Showing 131-140 of 5643 results for "".
Sleep + DED • Motivating Staff
https://modernod.com/podcasts/the-mod-pod/sleep-ded-motivating-staff/36878/This month on The MOD Pod, host Cecelia Koetting, OD, FAAO, Dipl ABO, welcomes guests Josh Davidson, OD, FAAO, FSLS, and Marlon Monelyon-Demeritt, OD, MBA, FAAO. Dr. Koetting and Dr. Davidson discuss the relationship between sleep and risk level of dry eye disease, with Dr. Davidson citing studies t89. Five Years Deep: Optometry Happy Hour Edition
https://modernod.com/podcasts/four-eyes/89-five-years-deep-optometry-happy-hour-edition/37039/In honor of the podcast’s fifth year anniversary, Deepon and Amrit host another popular Happy Hour episode and play an Optometry version of “Have You Ever”. So grab your drink, sit back, and listen as our two hosts go down memory lane of their most wild patient experiences!The Four Eyes Podcast is bLLLT and AMD: Your Questions Answered
https://modernod.com/topics/retina/lllt-and-amd-your-questions-answered/37350/Joseph J. Allen, OD, FAAO, Dipl ABO, gives an overview of a recently FDA-authorized low-level light therapy, or photobiomodulation, device, the Valeda Light Delivery System (LumiThera). He explains the device’s unique mechanism of action for treating age-related macular degeneration, reviews promisiWater-Free Ciclosporin-Based Eye Drop for DED Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/water-free-ciclosporin-based-eye-drop-for-ded-approved-in-europe/37052/Novaliq’s water-free ciclosporin-based eye drop for dry eye disease is approved in Europe; the FDA approves first new ophthalmic steroid in over 15 years; and the first slit-lamp mounted rebound tonometer is launched in the US and Europe.Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08212024/37046/Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics Acquires Visiox PharmaceuticalsWeekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-08142024/37045/Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap • Lensar Receives European Approval for ALLY System • Lenz Therapeutics Submits NDA for Presbyopia Eye DropThe Parasympathetic Nervous System and DED
https://modernod.com/topics/ocular-surface/the-parasympathetic-nervous-system-and-ded/38791/The connection between the two suggests dry eye is more than just a disease of the eye.New Drugs for Dry Eye and Demodex Blepharitis
https://modernod.com/topics/ocular-surface/new-drugs-for-dry-eye-and-idemodexi-blepharitis/38625/More options, more personalized treatment for patients. Get familiar with what may end up in your toolbox.Use of Imaging Technology to Detect AMD and GA
https://modernod.com/topics/retina/use-of-imaging-technology-to-detect-amd-and-ga/36841/Carlo J. Pelino, OD, FAAO, hosts this special edition of the MODPod and speaks with guests Carolyn Majcher, OD, and Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO. The panel of expert optometrists discusses how to approach patients with age-related macular degeneration (AMD) in the early and i[Genetics and Eyecare Today] Common Questions Patients Ask Genetic Counselors and How to Talk to Them About Testing
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-common-questions-patients-ask-genetic-counselors-and-how-to-talk-to-them-about-testing/36809/In the latest special edition episode of The MOD Pod's mini series Genetics and Eyecare Today, the focus is on the patient. Drs. Elizabeth Yeu and Melissa Barnett speak with a genetic counselor at Avellino, who explains what to expect from a genetic counseling session and answers common questions pa